UoH Hyderabad Protein Biochemistry/Structural Biology JRF Opening

School of Life Sciences 
Department of Biotechnology & Bioinformatics
University of Hyderabad 

No. UH/LS/BT/IAQ/SERB-25/Advt-1 Date: August 18, 2025 

Applications are invited from eligible candidates (Indian Nationals only) on a plain paper or in the prescribed format (Form-B) for the following temporary position(s) in the research project entitled “Comprehensive proteomics approach to characterize the leishmanial proteins as targets for novel therapeutics” sponsored by Science and Engineering Research Board (SERB). 

1 Name of the Post Junior Research Fellow (One) 

2 Number of positions One 

3 Fellowship / Honorarium INR 37,000/- 

4 HRA, if applicable 24% HRA 

5 Tenure of the Post For 11 months or till the end of the project, whichever is earlier. 

6 Essential Qualifications MSc/MTech in Biochemistry/ Biotechnology/ Bioinformatics or equivalent with at least 60% aggregate marks with NET/GATE qualification. 

7 Desirable Qualifications Candidates having experience of molecular biology, protein biochemistry, and structural biology will be preferred. 

8 Experience - 

1. Applicants should note that the appointments to be made are purely temporary and there is no right for claiming for any regular appointment in the University. 
2. No TA/DA will be paid for attending the written test/interview or at the time of joining the post. 
3. Self-Attested copies of all certificates in support of the information furnished in the application should be enclosed. 
4. Last date for receipt of filled-in applications is: 5.00 pm on August 31, 2025. 
5. Address to which the applications should be sent: By e-mail to insaf@uohyd.ac.in with subject “Application for SERB-JRF”. (Note: Only eligible candidates will be informed by email / letter at a later date for an online interview) ________ Signature of the applicant

More Info: https://uohyd.ac.in/jrf-srf/#

Subscribe our X Channel  to get Latest and more updates: Join Now!

To Get All Updates from helpBIOTECH, Subscribe Now by Email

Post a Comment

0 Comments